Clinical Trial Update: A Study of PN20 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study of PN20 in healthy adult volunteers has been completed; the trial investigated dosing in conditions including chemotherapy-induced thrombocytopeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Immune Thrombocytopenic Purpura

Drugs mentioned

• PN20

Snippet

Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. | Conditions: Chemotherapy-induced Thrombocytopenia, Immune Thrombocytopenic Purpura | Phase 1 | Status: COMPLETED